2/20
04:44 pm
gh
Rating for GH
Low
Report
Rating for GH
2/20
04:05 pm
gh
Rating for GH
Low
Report
Rating for GH
2/20
04:05 pm
gh
Rating for GH
Low
Report
Rating for GH
2/20
03:54 pm
gh
Rating for GH
Low
Report
Rating for GH
2/20
02:19 pm
gh
Rating for GH
Low
Report
Rating for GH
2/20
12:56 pm
gh
Rating for GH
Low
Report
Rating for GH
2/20
12:56 pm
gh
Rating for GH
Low
Report
Rating for GH
2/20
09:19 am
gh
Rating for GH
Medium
Report
Rating for GH
2/20
08:51 am
gh
Rating for GH
Medium
Report
Rating for GH
2/20
07:18 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
2/20
06:07 am
gh
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Medium
Report
Guardant Health (NASDAQ:GH) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/20
05:14 am
gh
Rating for GH
Medium
Report
Rating for GH
2/18
06:57 am
gh
Guardant Health (NASDAQ:GH) was upgraded by analysts at Robert W. Baird to a "strong-buy" rating.
Low
Report
Guardant Health (NASDAQ:GH) was upgraded by analysts at Robert W. Baird to a "strong-buy" rating.
2/17
05:41 am
gh
Rating for GH
Low
Report
Rating for GH
2/17
05:41 am
gh
Rating for GH
Low
Report
Rating for GH
2/17
05:08 am
gh
Guardant Health initiated with an Outperform at Baird
Low
Report
Guardant Health initiated with an Outperform at Baird
2/17
05:08 am
gh
Guardant Health initiated with an Outperform at Baird
Low
Report
Guardant Health initiated with an Outperform at Baird
1/30
10:58 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at UBS Group AG.
1/26
11:33 am
gh
Rating for GH
Low
Report
Rating for GH
1/26
11:33 am
gh
Rating for GH
Low
Report
Rating for GH
1/26
10:02 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/26
10:02 am
gh
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Guardant Health (NASDAQ:GH) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/9
09:24 am
gh
Rating for GH
Low
Report
Rating for GH
1/6
07:25 am
gh
Guardant Health (NASDAQ:GH) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Medium
Report
Guardant Health (NASDAQ:GH) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
1/6
07:25 am
gh
Guardant Health (NASDAQ:GH) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Medium
Report
Guardant Health (NASDAQ:GH) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.